Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
BPC-157 is a synthetic peptide derived from a sequence originally studied within protective peptide signaling pathways
Tirzepatide (Mounjaro, Zepbound) averages roughly 2022.5% body-weight loss versus about 15% for semaglutide (Wegovy) and 1014% for Ozempic (SURMOUNT/STEP trial data)
Avoid vendors offering steep discounts that fall well below industry market averages
Physicians certified by the Canadian Board of Obesity Medicine have completed additional training in the complex biology of weight regulation and the nuances of pharmacological treatment
US$ 27.58
US$ 20.09
US$ 26.61
US$ 23.07
